MedTrace Logo

Uterine Balloon Treatment for Heavy Period Bleeding.

NCT00215618 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2009-01-14

No results posted yet for this study

Summary

The purpose of this research is to determine the proportion of women who achieve permanent cessation of bleeding after Uterine Balloon Therapy (UBT) for the treatment of heavy uterine bleeding.

Conditions

  • Menorrhagia

Interventions

DEVICE

Uterine Balloon Therapy

UBT with post procedure curettage

DEVICE

Uterine Balloon Therapy

UBT without post procedure curettage

Sponsors & Collaborators

  • Ethicon, Inc.

    lead INDUSTRY

Principal Investigators

  • Charles T Cash, MD · Oakwood Hospital and Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2006-08-31
Completion
2008-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00215618 on ClinicalTrials.gov